Important Interactions of Immunosuppressants With Experimental Therapies for Novel Coronavirus Disease (COVID-19): How to Act-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Important Interactions of Immunosuppressants With Experimental Therapies for Novel Coronavirus Disease (COVID-19): How to Act

Published:2020-08 Issue:4 Volume:42 Page:652-653
ISSN:0163-4356
Container-title:Therapeutic Drug Monitoring
language:en
Short-container-title:

Author:

Zijp Tanja R.,Toren-Wielema Martha L.,Nannan Panday Prashant V.,Kosterink Jos G. W.,Berger Stefan P.,Touw Daan J.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Pharmacology

Reference10 articles.

1. A trial of lopinavir–ritonavir in adults hospitalized with severe covid-19;Cao;N Engl J Med.,2020

2. Pharmacokinetics and dose recommendations for cyclosporine and tacrolimus when coadministered with ABT-450, ombitasvir, and dasabuvir;Badri;Am J Transpl.,2015

3. Kidney transplant in a human immunodeficiency virus-positive patient: case report of drug interactions;Yilmaz;Exp Clin Transpl.,2017

4. Pharmacokinetics of tacrolimus and cyclosporine in liver transplant recipients receiving 3 direct-acting antivirals as treatment for hepatitis C infection;Badri;Ther Drug Monit.,2016

5. Sirolimus oral bioavailability increases ten-fold with concomitant ketoconazole;Floren;Clin Pharmacol Ther.,1999

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of SARS-CoV-2 and Persistent Viral Detection in Solid Organ Transplant Recipients;Current Pulmonology Reports;2024-02-24

2. Therapeutic Drug Monitoring and Dosage Adjustments of Immunosuppressive Drugs When Combined With Nirmatrelvir/Ritonavir in Patients With COVID-19;Therapeutic Drug Monitoring;2023-04

3. Cardiovascular Drug Interactions With Nirmatrelvir/Ritonavir in Patients With COVID-19;Journal of the American College of Cardiology;2022-11

4. Evolution of Clinical Care in COVID-Infected Solid Organ Transplant Recipients;Current Transplantation Reports;2022-05-31

5. Alternative Management of Cushing's Syndrome During Covid-19 Pandemic;Coronaviruses;2021-09-13

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3